홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

(3,5-dimethylpyrazol-1-yl)-(9H-xanthen-9-yl)methanone → N-[5-(2-methoxyethyl)-1,3,4-oxadiazol-2-yl]-9H-xanthene-9-carboxamide

HRID 392730
인쇄

반응식

HRID 392730 반응식
CC1C=[C:5](C)[N:4]([C:8]([CH:10]2[C:23]3[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=3[O:17][C:16]3[C:11]2=[CH:12][CH:13]=[CH:14][CH:15]=3)=[O:9])N=1.[CH3:24][O:25][CH2:26][CH2:27][C:28]1[O:32]C(N)=[N:30][N:29]=1>>[CH3:24][O:25][CH2:26][CH2:27][C:28]1[O:32][C:5]([NH:4][C:8]([CH:10]2[C:11]3[CH:12]=[CH:13][CH:14]=[CH:15][C:16]=3[O:17][C:18]3[C:23]2=[CH:22][CH:21]=[CH:20][CH:19]=3)=[O:9])=[N:30][N:29]=1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 4521579(3,5-dimethylpyrazol-1-yl)-(9H-xanthen-9-yl)methanoneHCID 226610755-(2-Methoxyethyl)-1,3,4-oxadiazol-2-amine

생성물 1

HCID 56763942N-[5-(2-methoxyethyl)-1,3,4-oxadiazol-2-yl]-9H-xanthene-9-carboxamide

실험 절차

The title compound, white solid, m.p. 204° C. and MS: m/e=351.1 (M+H+) was prepared in accordance with the general method of example 44a from (3,5-dimethylpyrazol-1-yl)-(9H-xanthen-9-yl)-methanone and [5-(2-methoxy-ethyl)-[1,3,4]oxadiazol-2-yl]-amine.

출처 및 근거

ORD 기록
ord-5b80d0d107804cfd8251c9d103eaf7e7
출처 데이터셋
uspto-grants-2004_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06803381B1

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트